[Therapeutic choice for the chronic myeloid leukemia patients in chronic phase showing late suboptimal response to imatinib].
Matsumura I, Nannya Y, Nagai T, Tanimoto K, Fujikawa K, Kasai M, Inaguma Y, Takeuchi M, Niimi H, Kashiwagi H, Imamura Y, Yagi T, Sakamoto E, Okabe M, Aoki G, Katayama T, Okada M, Adachi Y, Saburi Y, Kizaki M.
Matsumura I, et al. Among authors: yagi t.
Rinsho Ketsueki. 2010 Dec;51(12):1762-8.
Rinsho Ketsueki. 2010.
PMID: 21258186
Japanese.